Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 69 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9096496

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  2. US 9096625

    BCL-2/BCL-XL inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  3. US 9095593

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  4. US 9096609

    Macrocyclic LRRK2 kinase inhibitors

    Oncodesign SA · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  5. US 9096602

    Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  6. US 9096584

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  7. US 9096501

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  8. US 9090597

    Pyrazolone derivatives as PDE4 inhibitors

    TAKEDA GMBH · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  9. US 9090589

    Specific nNOS inhibitors for the therapy and prevention of human melanoma

    The Regents of the University of California · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  10. US 9090630

    Macrocyclic FLT3 kinase inhibitors

    Oncodesign SA · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  11. US 9089545

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  12. US 9084782

    Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis

    The Regents of the University of California · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  13. US 9084828

    Oligomer-protein tyrosine kinase inhibitor conjugates

    Nektar Therapeutics · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  14. US 9079944

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  15. US 9079898

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  16. US 9073918

    Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5

    Takeda Pharmaceutical Company Limited · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  17. US 9073875

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

    Vertex Pharmaceuticals Incorporated · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  18. US 9067989

    Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  19. US 9067932

    Pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  20. US 9066944

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  21. US 9062008

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  22. US 9062007

    Cyclic amide BACE-1 inhibitors having a benzamide substituent

    Pharmacopeia Drug Discovery, Inc. · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  23. US 9062002

    Substituted pyridine derivatives as FabI inhibitors

    Aurigene Discovery Technologies Limited · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  24. US 9062068

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.